The FDA analysts also raised concerns about whether women with medical conditions that should preclude them from taking the pill, primarily breast cancer and undiagnosed vaginal bleeding, would avoid the product.
State Sen. Lynda Wilson (R-Vancouver) criticized the legislation, stating, “HB 1240 clearly violates our state and federal constitutions, which is why it will end up in court immediately."
